This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...

Excellergy has been snapped up by the Swiss pharma only five months after emerging with $70 million in funds. The Palo Alto, ...

Techcyte has been named 2025 Infectious Disease Testing Solution of the Year by the BioTech Breakthrough Awards, a leading ...

Some investors and analysts believe the pharma’s $6.7 billion offer is justified given Terns’ recent stock run. Others are ...

The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.

By Marleen Kaesebier and Bhanvi Satija March 27 (Reuters) - Swiss drugmaker Novartis will buy California-based biotech ...

Attend or sponsor our commercial real estate event in San Francisco: Bay Area Life Sciences & Biotech Conference.

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

An Allston mixed-use project has secured its first lab tenant since opening last year. King Street Properties' Allston ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...